Artia Global Partners LP Purchases New Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)

Artia Global Partners LP purchased a new stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 99,267 shares of the company’s stock, valued at approximately $19,506,000. Karuna Therapeutics comprises about 7.4% of […]

Related Keywords

Boston ,Massachusetts ,United States ,Hong Kong ,Stephenk Brannan ,Lauriej Olson ,Eric Elenko ,Peter Jeffrey Conn ,Andrew Miller ,Cantor Fitzgerald ,Karuna Therapeutics Company Profile ,Hong Kong Ltd ,Nasdaq ,Almanack Investment Partners ,Exchange Commission ,Securities Exchange Commission ,Advisors Inc ,Karuna Therapeutics Inc ,Jpmorgan Chase Co ,Artia Global Partners ,Karuna Therapeutics ,Get Rating ,Global Partners ,Investment Partners ,Kong Ltd ,Director Laurie ,Karuna Therapeutics Daily ,